Evidence map›Paper›PMID 25187660›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

Cutting edge: the UNC93B1 tyrosine-based motif regulates trafficking and TLR responses via separate mechanisms.

Karin Pelka, Kshiti Phulphagar, Jana Zimmermann, Rainer Stahl, Jonathan L Schmid-Burgk, Tobias Schmidt, Jan-Hendrik Spille, Larisa I Labzin, Sudhir Agrawal, Ekambar R Kandimalla and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 3 countries.

Karin PelkaInstitute of Innate Immunity, University Hospital, University of Bonn, 53127 Bonn, Germany;
Kshiti PhulphagarInstitute of Innate Immunity, University Hospital, University of Bonn, 53127 Bonn, Germany;
Jana ZimmermannInstitute of Biochemistry I and Center for Molecular Medicine Cologne, University of Cologne, 50931 Cologne, Germany;
Rainer StahlInstitute of Innate Immunity, University Hospital, University of Bonn, 53127 Bonn, Germany;
Jonathan L Schmid-BurgkInstitute of Molecular Medicine, University Hospital, University of Bonn, 53127 Bonn, Germany;
Tobias SchmidtInstitute of Molecular Medicine, University Hospital, University of Bonn, 53127 Bonn, Germany;
Jan-Hendrik SpilleInstitute of Physical and Theoretical Chemistry, University of Bonn, 53121 Bonn, Germany;
Larisa I LabzinInstitute of Innate Immunity, University Hospital, University of Bonn, 53127 Bonn, Germany;
Sudhir AgrawalIdera Pharmaceuticals, Cambridge, MA 02139;
Ekambar R KandimallaIdera Pharmaceuticals, Cambridge, MA 02139;
Jean-Laurent CasanovaSt. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY 10065; Howard Hughes Medical Institute, New York, NY 10065; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, 75015 Paris, France; Paris Descartes University, Imagine Institute, 75015 Paris, France; Pediatric Hematology-Immunology Unit, Necker Hospital for Sick Children, Public Assistance-Paris Hospitals, 75015 Paris, France;
Veit HornungInstitute of Molecular Medicine, University Hospital, University of Bonn, 53127 Bonn, Germany;
Ann Marshak-RothsteinDepartment of Medicine, University of Massachusetts Medical School, Worcester, MA 01655; and.
Stefan HöningInstitute of Biochemistry I and Center for Molecular Medicine Cologne, University of Cologne, 50931 Cologne, Germany;
Eicke LatzInstitute of Innate Immunity, University Hospital, University of Bonn, 53127 Bonn, Germany; Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01655; and German Center for Neurodegenerative Diseases, 53175 Bonn, Germany eicke.latz@uni-bonn.de.
University of Bonn · DEIdera Pharmaceuticals (United States) · USUniversity Hospital Bonn · DEUniversity of Cologne · DEUniversity of Massachusetts Chan Medical School · USAssistance Publique – Hôpitaux de Paris · FR

Funding

Toll-Like Receptors in Systemic Autoimmune DiseaseP01AR050256 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SHLOMCHIK, MARK J · 2004 to 2013
$13.4M
Distinct Functional Outcomes of BCR/TLR7 and BCR/TLR9 Co-engagementR01AR066808 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MARSHAK-ROTHSTEIN, ANN · 2015 to 2019
$2.6M
NIAMS NIH HHS P01 AR050256NIAMS NIH HHS P01-AR050256NIAMS NIH HHS R01 AR066808
6 · The paper itself

Abstract

Sensing of nucleic acids by TLRs is crucial in the host defense against viruses and bacteria. Unc-93 homolog B1 (UNC93B1) regulates the trafficking of nucleic acid-sensing TLRs from the endoplasmic reticulum to endolysosomes, where the TLRs encounter their respective ligands and become activated. In this article, we show that a carboxyl-terminal tyrosine-based sorting motif (YxxΦ) in UNC93B1 differentially regulates human nucleic acid-sensing TLRs in a receptor- and ligand-specific manner. Destruction of YxxΦ abolished TLR7, TLR8, and TLR9 activity toward nucleic acids in human B cells and monocytes, whereas TLR8 responses toward small molecules remained intact. YxxΦ in UNC93B1 influenced the subcellular localization of human UNC93B1 via both adapter protein complex (AP)1- and AP2-dependent trafficking pathways. However, loss of AP function was not causal for altered TLR responses, suggesting AP-independent functions of YxxΦ in UNC93B1.

Indexed as

Adaptor Protein Complex 1Adaptor Protein Complex 2Amino Acid MotifsB-LymphocytesCell Line, TumorHEK293 CellsHumansMembrane Transport ProteinsMonocytesProtein TransportToll-Like ReceptorsAdaptor Protein Complex 1Adaptor Protein Complex 2Membrane Transport ProteinsToll-Like ReceptorsUNC93B1 protein, human

Identifiers

PMID25187660
PMCPMC4170058
OpenAlexW2103287192

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.